Natural Cycles integration unlocks FDA-cleared birth control app for users with select Garmin smartwatches
Rhea-AI Summary
Garmin (NYSE: GRMN) announced an integration with Natural Cycles, the FDA-cleared app for birth control, enabling compatible Garmin smartwatches to share overnight skin temperature for fertility insights.
Compatible models include fēnix 8, Forerunner 570, Forerunner 970, Venu 4, and Venu X1. The feature automatically syncs morning data to Natural Cycles and is available in Australia, Brazil, Canada, EU, Norway, Singapore, Switzerland, UK, and the US.
Positive
- Enables FDA-cleared birth control app via Garmin skin temperature
- Supports five smartwatch models: fēnix 8, Forerunner 570, Forerunner 970, Venu 4, Venu X1
- Availability across nine countries including US, UK, EU, Canada, Brazil
Negative
- Limited device compatibility: only select Garmin models supported
- Geographic limits: feature available in nine countries only
Key Figures
Market Reality Check
Peers on Argus
GRMN was down 1.81% with peers like COHR -11.28%, KEYS -5.34%, TDY -3.15%, TRMB -1.84%, and FTV -1.69% also negative, but no peers appeared in the momentum scanner, suggesting a stock-specific reading of this smartwatch–health app integration amid broader sector weakness.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 25 | Earnings call scheduled | Neutral | +1.5% | Announced timing for Q1 2026 earnings release and conference call. |
| Mar 17 | Smartwatch app update | Neutral | +0.1% | Introduced WhatsApp app availability for select Garmin smartwatches. |
| Mar 10 | New sonar product | Neutral | -0.5% | Launched GT360UHD 360-degree sonar and Spy Pole bundles for anglers. |
| Mar 03 | Community program | Neutral | -1.8% | Announced Garmin Community Champions recognition at marathon series events. |
| Feb 25 | SOS report release | Neutral | +0.2% | Released 2025 inReach SOS incident report and usage statistics. |
Recent Garmin news and product updates have typically been followed by modest single-day moves, with no strong pattern of outsized gains or selloffs.
Over the past months, Garmin has focused on product innovation and ecosystem expansion, from a WhatsApp app for select smartwatches to advanced 360-degree sonar hardware and community engagement programs. An upcoming Q1 2026 earnings call on April 29, 2026 is the next scheduled catalyst. The Natural Cycles integration fits this pattern of enhancing health and connectivity features within its smartwatch lineup rather than signaling a major strategic shift.
Market Pulse Summary
This announcement expands Garmin’s smartwatch ecosystem by integrating with the Natural Cycles app, an FDA class II birth control and fertility-tracking tool, on select devices. It reinforces Garmin’s focus on women’s health and broader wellness capabilities rather than introducing financial guidance or major strategic shifts. Investors may watch how quickly the integration rolls out across listed countries, user adoption trends within the app, and any related commentary during the upcoming Q1 2026 earnings call.
Key Terms
fda-cleared regulatory
class II medical device regulatory
non-hormonal birth control medical
AI-generated analysis. Not financial advice.
Garmin users can now integrate with the temperature-powered Natural Cycles app, which turns Garmin skin temperature data into fertility insights for women's health
"Women all over the world utilize Garmin products for activity and health tracking, which is why this integration with Natural Cycles, a pioneer in women's digital health, is so important. As we continue to help women meet their fitness and wellness goals, we are proud that Garmin skin temperature can be used within the Natural Cycles app for those looking for a non-hormonal approach to birth control."
—Susan Lyman, Garmin Vice President of Consumer Sales and Marketing
Sleep. Track. Unlock.
The Natural Cycles (NC°) app, an FDA class II medical device intended to prevent and plan pregnancy, analyzes body temperature and other key fertility indicators to determine each user's unique daily fertility status. With the launch of this integration, Natural Cycles users can now wear a compatible Garmin smartwatch to bed; skin temperature is tracked overnight and automatically syncs with the NC° app in the morning.
"For Natural Cycles, integrating with a hardware leader like Garmin is a natural next step as we expand our wearable ecosystem. This product integration marks an exciting milestone, enabling us to bring our non-hormonal birth control to even more women worldwide and offering an effective, hormone-free way to prevent or plan pregnancy."
—Dr. Elina Berglund Scherwitzl, Natural Cycles Co-Founder and CEO
The Garmin and Natural Cycles integration is available in the following countries at this time:
To learn more about the integration, go to the Natural Cycles landing page.
Engineered on the inside for life on the outside, Garmin products have revolutionized life for adventurers, athletes, and outdoor enthusiasts everywhere. Committed to developing products that enhance experiences and enrich lives, Garmin believes every day is an opportunity to innovate and a chance to beat yesterday. Visit the Garmin Newsroom, email our media team, connect with @garmin on social, or follow our blog.
About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in
All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved.
About Natural Cycles°
Founded in 2013 by physicists Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, Natural Cycles is a leading women's digital health company dedicated to transforming how women understand and manage their reproductive health. The company developed the world's first FDA-cleared digital method of birth control—delivered through an app and powered by a proprietary algorithm that interprets biomarker data to provide personalized cycle insights and daily fertility status. NC° Birth Control has received regulatory authorization across the US,
Notice on Forward-Looking Statements:
This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management's current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 27, 2025, filed by Garmin with the Securities and Exchange Commission (Commission file number 0-31983). Copies of such Form 10-K are available at https://www.garmin.com/en-US/investors/sec/. No forward-looking statement can be guaranteed. Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
MEDIA CONTACTS:
Elliott Scott
913-397-8200
media.relations@garmin.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/natural-cycles-integration-unlocks-fda-cleared-birth-control-app-for-users-with-select-garmin-smartwatches-302728969.html
SOURCE Garmin International, Inc.
FAQ
Which Garmin smartwatches work with Natural Cycles for birth control (GRMN)?
How does Garmin skin temperature data integrate with Natural Cycles (GRMN)?
Is the Natural Cycles app FDA-cleared for birth control when used with Garmin (GRMN)?
In which countries is the Garmin and Natural Cycles integration available (GRMN)?
How do users enable sleep temperature tracking for Natural Cycles on Garmin watches (GRMN)?
What does the Garmin–Natural Cycles integration mean for users seeking non-hormonal birth control (GRMN)?
